Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
about
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugsGene-environment interactions in schizophrenia: review of epidemiological findings and future directionsAcetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levelsROS and brain diseases: the good, the bad, and the uglyDysregulated mitochondrial and chloroplast bioenergetics from a translational medical perspective (Review)Progress in pharmacogenetics: consortiums and new strategiesTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsAssociation between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetesThe role of Abcb5 alleles in susceptibility to haloperidol-induced toxicity in mice and humansAntipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks.The person and philosophy of science and medicineThe role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.Age-dependent regulation of synaptic connections by dopamine D2 receptors.Theranostic Biomarkers for SchizophreniaThe impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum.The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variationPharmacogenetics of antipsychotics.Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia.Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.The schizophrenia risk gene ZNF804A influences the antipsychotic response of positive schizophrenia symptoms.Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysisAntipsychotic drugs and obesity.A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophreniaGenome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects predictionPersonalized medicine in psychiatry: problems and promises.Genomewide association study of movement-related adverse antipsychotic effects.Clinically significant psychotropic drug-drug interactions in the primary care setting.The promise and reality of pharmacogenetics in psychiatryPersonalized medicine in psychiatry: ethical challenges and opportunities.How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?Exploring schizophrenia drug-gene interactions through molecular network and pathway modelingDissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers.Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studiesEvaluation of genetic association of neurodevelopment and neuroimmunological genes with antipsychotic treatment response in schizophrenia in Indian populations.Utilizing yeast chemogenomic profiles for the prediction of pharmacogenomic associations in humans.Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine.
P2860
Q24630309-3B2EFB53-1F2E-4A8C-BA11-E0FA565C5D94Q24643775-910040B9-4601-4A14-9B6B-EEFCC25CFFC8Q24649745-AB192168-515A-48CC-92C5-C765A3614376Q27014070-75E1D0B9-83EF-4495-B2D1-71A4361A8F6EQ28066841-F0BE16DA-DB3A-4329-BEDB-E8EEFADC7BA3Q28071652-33C15333-4E1E-4A90-9446-8DFC92D5B110Q28079065-46563285-F92A-4E33-B6F4-74CDF817C8D2Q28264722-B2657D37-F9C8-449D-9B01-090D09867EE4Q28475961-B9758927-AA96-4B97-9BDA-6F3F545CAF3EQ28543192-C3FEA44A-7218-402B-B2A7-FDBE3E0F91D1Q30370326-05808CB5-95AA-4F82-9FAA-E0DAC1C69217Q30386663-E1D1A39B-E833-42E4-AFDB-4E005ABD9D95Q30437188-F89DFF5F-C1CB-4980-9DA6-C859CFDC9B57Q30557426-201DE1AB-9162-4A2C-9B00-CC1E404CFBC5Q33624412-12C58F00-B16A-4D8A-8CE4-64C4D37F8442Q33635632-EBD2EF86-75E4-4DB5-A459-6D639D0D5965Q33802672-01859131-6FAD-4CC1-93D7-7D8AD9F5EDDEQ33836837-AD759F7B-2702-42A6-AEC5-AC0D4F7D9E8DQ33926334-9D444A36-4BD5-4827-9484-812650FCF962Q34061159-C13A15E6-C96A-4E86-82C0-6C83FB1A9D74Q34131354-9D6696B3-CA28-41F4-9C45-7447EAB99C85Q34213593-F26B7EC8-7228-44C0-B5D7-FCDE2B36EE50Q34274859-BE3A260A-1D22-4066-A91F-CFCD46E83D35Q34393431-27A09EAB-80F7-4074-A794-C0EA59D86A77Q34648940-21C8CD12-AFFB-404B-AA00-4E3E724D0B4DQ34655540-60BB1E21-45DE-467F-BBAA-BC617C4DD2B0Q34661875-E24AFCC7-3EDE-4B17-A492-A5E8D1905E5FQ34676533-E73E3859-5D72-4C87-ABF6-2A22B1ABDE91Q34726454-7D9A9823-26E4-48EF-941E-5F1CC4D97FDEQ35010386-A9AC119B-28E5-4B7E-8E47-DDFDB28A9705Q35104220-4072E106-4746-437E-9D02-4A1C7DCE43A0Q35226451-276F88A9-6059-4DD9-B85E-9898C6462E69Q35237132-536DFB5A-AC76-44CC-8DD1-713083C0BBEBQ35610726-6D4F6D3D-0817-4400-AB38-14073FFD579FQ35624956-D973858E-9D30-4337-A3A9-0283379770E5Q36168593-F110056D-9EC7-43BC-A21B-5710BED8BDF2Q36230583-BCA4AD8A-377E-4BEF-AFCA-96FEAFCFEC6FQ36447406-DC25CA97-B391-4360-A5A8-81D111E0108CQ36741638-4383CBB6-801E-4CA8-A769-707248D588BBQ36754038-7605B4A9-7D3F-4E1D-A7EC-CF1B83AC8BE3
P2860
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pharmacogenetics and pharmacog ...... ew of last decade of research.
@en
type
label
Pharmacogenetics and pharmacog ...... ew of last decade of research.
@en
prefLabel
Pharmacogenetics and pharmacog ...... ew of last decade of research.
@en
P2860
P356
P1433
P1476
Pharmacogenetics and pharmacog ...... ew of last decade of research.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.MP.4002009
P407
P577
2007-06-05T00:00:00Z
P5875
P6179
1042780954